[Skip to the questions](#main)

Tirzepatide questions you can take along

[Quick card](/quick-card/) [Cost worksheet](/cost-cards/worksheet/)

[ t.   Tirzepatide care notes  ](/)

Menu

Start & understand

- [Guide home](/)

- [Choose a care route](/start-here/)

- [The short visit card](/quick-card/)

- [The full question kit](/question-cards/)

- [Make sense of answers](/answer-cards/)

- [Name the medicine](/answer-cards/medicine/)

- [Pharmacy-made versions](/answer-cards/compounding/)

Check & prepare

- [Check who would treat you](/question-cards/clinician/)

- [Check the pharmacy](/question-cards/pharmacy/)

- [The online visit](/question-cards/online-visit/)

- [Bring your health history](/question-cards/first-visit/)

- [Ask about later care](/question-cards/follow-up/)

- [Health questions](/safety-cards/)

- [Claims to question](/warning-cards/)

Cost & proof

- [The full cost](/cost-cards/)

- [Your cost worksheet](/cost-cards/worksheet/)

- [Ask about coverage](/coverage-cards/)

- [Read the study results](/evidence-cards/)

- [Sources for your checks](/source-cards/)

The longer view

# Ask what happens after the first visit.

An offer needs more than a first visit and a delivery. Ask who stays involved, what later care includes and how the plan can change.

Ask it in plain words

Who stays involved after the care decision?

On this card
[Make the contact route clear](#card-1) [Plan later care and stopping](#card-2) [Discuss stopping before it becomes urgent](#card-3) [Sources for this chapter](#chapter-sources)

## Make the contact route clear

FDA flags online care when no doctor with a licence is available to answer questions after the medicine arrives.

- Who reads a message about a health concern?

- What is the contact route for the person responsible for my care?

- What reply time does the service commit to?

- What care is available when that person is away?

## Plan later care and stopping

Request a plan you can describe back to the person treating you. Include changes in your health or your goals, rather than treating each visit as a refill task.

- What are we checking at later visits?

- How will we judge progress beyond a scale reading?

- What changes in my health do you want to hear about?

- Which visits are included in the quoted fee?

### Discuss stopping before it becomes urgent

In the SURMOUNT-4 study, people switched from tirzepatide to a shot without the medicine regained weight. People who continued tirzepatide lost more weight.

A study cannot decide your care plan. Ask the person treating you how to think about stopping, cost changes or a wish to try another approach.

- What support is available if we decide to stop?

- What happens if I cannot keep paying?

- Can I keep copies of my records if I move to another service?

- Does leaving the care plan also cancel the membership?

## Sources for this chapter

Use these sources to check the answers above. Bring any questions to the person treating you.

- [FDA · support after medicine arrives](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss)

- [JAMA via PubMed · the study of continued treatment](https://pubmed.ncbi.nlm.nih.gov/38078870/)

[  Keep the question moving  Name the medicine   ↗ ](/answer-cards/medicine/)

These pages help you ask about care. This is a guide with no medical services; it does not sell products.

[Question kit](/question-cards/)  [Short visit card](/quick-card/)  [Source cards](/source-cards/)  [Text copy of this page](/question-cards/follow-up/index.md)